Aryeh Jason
SEC Form 4 insider trading activity
Aryeh Jason has filed 7 SEC Form 4 filings (11 transaction rows) across 3 companies, including LGND, LFCR, OBIO, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.
On the most recent filing, Aryeh Jason is listed as Director at LIGAND PHARMACEUTICALS INC. Inside the rolling window, Aryeh Jason reported 2 open-market purchases totaling $37K in OBIO and 2 open-market sales totaling $1.3M in LGND. The largest disclosed transaction in the window is a sale of 4,500 LGND shares on Jun 11, 2026, worth $1.1M.
Companies traded
Other insiders at LGND
Insider Buying
$37K
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Companies
3
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 23, 2025 | LGND | Sale | $164K |
| Sep 23, 2025 | LGND | Sale | $791K |
| Sep 23, 2025 | LGND | Sale | $753K |
| Sep 19, 2025 | OBIO | Purchase | $2K |
Frequently asked questions
How many SEC Form 4 filings has Aryeh Jason made?
Aryeh Jason has filed 7 SEC Form 4 filings (11 transaction rows) across 3 companies, including LGND, LFCR, OBIO since 2025.
Which companies does Aryeh Jason trade?
Aryeh Jason has filed SEC Form 4 disclosures for 3 companies, including LGND, LFCR, OBIO.
When was Aryeh Jason's most recent SEC Form 4 filing?
Aryeh Jason's most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.
What is Aryeh Jason's total buy and sell value in the current window?
Inside the rolling retention window, Aryeh Jason bought $37K and sold $1.3M based on SEC Form 4 filings.
What was Aryeh Jason's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,500 LGND shares on 2026-06-11, worth $1.1M, per SEC Form 4 filings.